Update on EMA & EU payers new initiative: Dialogue to explore synergies, foster mutual understanding & cooperation to improve timely & affordable access to new medicinal products
Tuesday, November 3, 2020 8:30 AM to 9:30 AM · 1 hr. (Africa/Abidjan)
Plenary Keynote
Information
• The role of regulators in establishing added benefit of novel therapies
• Where do we stand 3 years from kick-off?
• Defining “evidence by design”
• Gaining mutual understanding among all relevant decision-makers on appropriate clinical trial designs, with a view to using the entire spectrum of available methodologies
• What does the EMA & EU payers initiative mean for patients?